European Association of Dermato-Oncology 15th European Post-Chicago Melanoma Skin Cancer Meeting 2025

We are excited to extend our warmest invitation to you for the upcoming Interdisciplinary Global Conference on News in Melanoma/Skin Cancer “European Post Chicago Meeting” in 2025. After many successful years in Munich, we are thrilled to announce that our event will be moving to the vibrant city of Hamburg, Germany.

Since our first meeting in 2011, the Post-Chicago Meeting on Melanoma/Skin Cancer has grown into a key event, with the 2024 edition drawing over 470 attendees on-site and 300 more virtually. This conference has always offered a comprehensive and interactive experience, providing deep insights into the latest advancements in melanoma diagnostics and therapy, while fostering direct communication with the world’s leading experts.

Our move to Hamburg opens a new chapter for the conference. In this dynamic and historic city, we will continue our tradition of lively interaction among clinicians, researchers, and industry representatives. The 2025 conference will feature international key opinion leaders who will share cutting-edge research, present the latest clinical trial results, and engage in stimulating discussions on emerging therapies.

We look forward to welcoming you to Hamburg, where you will not only gain valuable scientific knowledge but also have the opportunity to connect with peers in a warm and familiar setting.

The 15th European Post-Chicago Melanoma / Skin Cancer Meeting 2025, organized by the European Association of Dermato-Oncology (EADO), is geared toward a highly specialized audience, including:

Dermatologists and oncologists involved in skin cancer diagnosis and treatment
Clinical researchers and translational scientists focused on melanoma and non-melanoma skin cancers
Pharmaceutical and biotech professionals working on immunotherapies, targeted therapies, and diagnostics
Healthcare professionals interested in the latest clinical trial data and therapeutic strategies
Medical trainees and fellows seeking updates on evidence-based practices in dermato-oncology

The event fosters interdisciplinary exchange and features international key opinion leaders, making it a hub for cutting-edge research and clinical insights.

+ Topics:

CLOSING REMARKS.mp4
KEYNOTE LECTURE I.mp4
KEYNOTE LECTURE II.mp4
KEYNOTE LECTURE III.mp4
LUNCH SATELLITE SYMPOSIUM V.mp4
Opening Of The Conference.mp4
PARALLEL SYMPOSIUM I Registry data and studies Update 2025.mp4
PARALLEL SYMPOSIUM II Cutaneous T-cell lymphoma (CTCL).mp4
PARALLEL SYMPOSIUM III Complex melanoma cases.mp4
PARALLEL SYMPOSIUM IV Complex non-melanoma cases.mp4
PP-15EPCM2025_Stand_26-06-25.pdf
SATELLITE SYMPOSIUM I.mp4
SATELLITE SYMPOSIUM II.mp4
SATELLITE SYMPOSIUM III.mp4
SATELLITE SYMPOSIUM IV.mp4
SATELLITE SYMPOSIUM VI.mp4
SYMPOSIUM I My personal highlights at ASCO 2025.mp4
SYMPOSIUM II Attacking tumor cells.mp4
SYMPOSIUM III Prognostic and predictive biomarkers.mp4
SYMPOSIUM IV Neoadjuvant perioperative treatment for skin cancer.mp4
SYMPOSIUM IX Is adjuvant treatment for melanoma dead.mp4
SYMPOSIUM V Adverse event management for ICI.mp4
SYMPOSIUM VI Adjuvant treatment of melanoma.mp4
SYMPOSIUM VII What’s new in guidelines and studies for….mp4
SYMPOSIUM VIII ImmTACs novel bi-specific agents for metastatic uveal and cutaneous melanomas.mp4
SYMPOSIUM X Melanoma survivorship.mp4